Personal Injury / Accidents- Auto Accidents
- Motorcycle Accidents
- Truck Accidents
- Construction Accidents
- Dog Bites
- Premise Liability / Slip & Fall
- Bankruptcy
- Criminal Defense/DUI's
- Estate Planning / Living Trusts
- Family Law
- Probate & Conservatorship
- Workers Compensation
- Other
- Aircraft Accidents
Bad Faith Insurance
- Class Actions
Child Abuse
Construction Defects
Consumer Fraud
Employee Rights
- Legal Malpractice
- Lemon Laws/ Auto Fraud
Medical Malpractice
Product Liability
Securities Fraud
- Nursing Home Abuse
- Social Security Disability
Whistle Blowers
Defective Products Attorneys
PPA or Phenylpropanolamine Lawyers
Serving Los Angeles, San Diego,
and the Southern California Areas
PPA (Phenylpropanolamine)
PPA is an ingredient in many over-the-counter cough and cold remedies, appetite suppressants and prescription decongestants.
Phenylpropanolamine is now believed to increase the risk of hemorrhagic stroke, especially in young women. Phenylpropanolamine is an ingredient used in prescription and over-the-counter drug products as a nasal decongestant to relieve stuffy nose or sinus congestion and in OTC weight control drug products to control appetite.
On May 11, 2000, FDA received results of a study conducted by scientists at Yale University School of Medicine that showed an increased risk of hemorrhagic stroke (bleeding of the brain) in people who were taking phenylpropanolamine. The Yale study helped show that the number of people having strokes when taking PPA was greater than the number of people having strokes who were not taking phenylpropanolamine. Although the risk of hemorrhagic stroke is very low, FDA has significant concerns because of the seriousness of a stroke and the inability to predict who is at risk.
If you suspect you may have adverse health reactions to PPA, contact a Defective Products Attorney in Los Angeles at Jacoby & Meyers about PPA or call us at 1-888-JACOBY-1.
© 2008 Copyright Jacoby & Meyers , LLC | Legal Website Design, Development and Optimization by Page 1 Solutions
